Search by Drug Name or NDC
NDC 70518-3225-01 Lorazepam 2 mg/mL Details
Lorazepam 2 mg/mL
Lorazepam is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is LORAZEPAM.
Product Information
| NDC | 70518-3225 |
|---|---|
| Product ID | 70518-3225_066fb0e7-d3e1-81d4-e063-6394a90acc49 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Lorazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lorazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | LORAZEPAM |
| Labeler Name | REMEDYREPACK INC. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA076150 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70518-3225-01 (70518322501)
| NDC Package Code | 70518-3225-1 |
|---|---|
| Billing NDC | 70518322501 |
| Package | 10 mL in 1 VIAL (70518-3225-1) |
| Marketing Start Date | 2022-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |